1.Comparison of life quality between surgical castration and drug castration in advanced prostate cancer
Chinese Journal of Biochemical Pharmaceutics 2016;36(12):53-56
Objective To explore the effects of surgical castration and intermittent androgen blockade (IAB) in patients with advanced prostate cancer.Methods 115 cases of advanced prostate cancer were selected including 48 cases with drug castration receiving IAB and 67 cases with surgical castration.Before the treatment, 6 months and 1 years after the treatment, the quality of life of the two groups was investigated by the quality of life questionnaire (EORTC QLQ-C30 +QLQ-PR25).Results Compared with before treatment, the general health status of the patients in the drug castration group and the surgical castration group were significantly improved (P<0.01), the whole body and the local pain were relieved (P<0.01) and the micturition symptoms were controlled ( P<0.01 ).The overall quality of life of drug castration group and surgical castration group were significantly decreased (P<0.05), and the degree of sexual function was particularly affected (P<0.01), but the body function of patients in drug castration group restored to a certain extent in drug castration group after 1 year’s treatment(P<0.01), while the quality of life in patients of surgical castration did not reverse.Conclusion Both of surgical castration and androgen deprivation therapy can reduce the quality of life of patients with advanced prostate cancer, but the adverse effects of drug treatment on the quality of life can be recovered in treatment intermission.
3.The effects of mutant influenza nonstructural protein 1 to IRF-3
Guoping ZHOU ; Jiqing CHEN ; Shenghua WU
Chinese Journal of Infectious Diseases 2000;0(02):-
Objective To explore the inhibitory effect of mutant influenza A viruses to the activation of interferon regulatory factor 3 (IRF-3). Methods HEK293 cells were infected with A/FM/1/47,A/HK/1/68, A/HK/1/68-MA20, A/HK/1/68-MA20C and positive control Sendai virus (SV). Whether the slowly moved phosphorylation form Ⅲ and Ⅳ of IRF-3 appeared or not was compared by Western blot in cells infected with these viruses. Wild type of NS1 from A/HK/1/68 and mutant NS1 from A/HK/1/68-MA20 were subcloned into pcDNA3.1-flag respectively. They were transfected in HEK 293 cells respectively. At 16 hours posttransfection, cells were infected with Sendai virus for 8 hours. Whole cell extracts were analyzed by Western blot and then probed with monoclonal flag antibody to check the expression of NS1, or with anti-IRF-3 to observe the inhibitory effects of the wild and mutant NS1 to the activated IRF-3. Luciferase assay was carried out by co-transfection with reporter plasmid, pGL2B with interferon ? promoter, and wild or mutant NS1 cDNA expression plasmid. SV was used to infect these cells after the co-transfection. Results Only less virulent A/HK/1/68-MA20 and positive control SV can activate IRF-3. Activated form Ⅲ and Ⅳ of IRF-3 began to appear 9 hours post infection (h.p.i), and most significant activated IRF-3 appeared 23 and 26 h.p.i. Sequence analysis of NS1 of MA20 revealed that nucleotide position number 94 is mutated from T to C, and amino acid at position number 23 is changed from valine to alanine. Co-transfected with wild type NS1 made form Ⅲ and Ⅳ of IRF-3 almost disappear, but not mutant NS1. In the luciferase functional analysis, wild type NS1 can inhibit the luciferase activity of IFN-? promoter, which was induced by SV, to around 1/10. Again no inhibitory effects was observed of mutant NS1 in the luciferase assay. Conclusion The mechanism that A/HK/1/68-MA20 can activate IRF-3 is that point mutant NS1 abolished the inhibitory function of NS1.
4.Structure and function of a truncated spliced isoform of interferon regulatory factor IRF-3c
Guoping ZHOU ; Jiqing CHEN ; Shenghua WU
Chinese Journal of Infectious Diseases 1997;0(04):-
Objective Interferon regulatory factors 3 (IRF-3) is a key transcription factor to regulate gene expression of interferon after virus infection. This study aims to look for new spliced isoforms of IRF-3 and to investigate their structures and functions. Methods RNA extracts from human embryonic kidney 293 cells were amplified by RACE and RT-PCR. New sequences were compared with published sequences of IRF-3 and murine EST database using bioinformatics method. A new sequence, IRF-3c, was subcloned into pcDNA3.1-flag. The IRF-3c/pcDNA3.1-flag plasmid was transfected in HEK 293 cells. Whole cell extract was analysed by Western blot and then probed with monoclonal Flag antibody. Luciferase assay was carried out by co-transfection with reporter plasmid, pGL2B with interferon ? promoter, and IRF-3c cDNA expression plasmid. At 16 hours posttransfection, cells were infected with Sendai virus for 8 hours. Cells were collected and assayed for luciferase activity. Results A novel spliced isoform of IRF-3, named IRF-3c was discovered. The new isoform is almost the same as IRF-3, except for the utilization of the 180 bp bases in intron 6 adjacent to exon 6. The first 2,3 and 4 bases are a stop codon, which may produce a protein with a truncated C-terminal stoped at amino acids 327. Western blot analysis confirmed an expected 44 kDa strong band. The new inserted bases can be found in murine EST database, suggesting a conservative function in evolution. The functional luciferase assay showed that IRF-3c inhibited the IFN? promoter activity to (around) 40%~50% as that of control after Sendai virus infection. Conclusions The discovery of a new isoform of IRF-3 provides a new insight into the functional regulation of IRF-3 family. It is a dominant-negative inhibitor for interferon ? promoter activity in the virus infection pathway, provides a mechanism for the fine-tuning of the virus-induced activation of the interferon response, and prevents interferon ? from its overexpression and its toxic effects. It is worthwhile to explore the role of IRF-3c in the pathogenesis of human diseases using IRF-3c’s specific sequence.
5.Application of Gukang Gold Far-Infrared Magnetic Therapeutic Paste to Treatment of Lateral Epicondylitis
Zhongde CHEN ; Shenghua HE ; Yonglin HAO
Chinese Medical Equipment Journal 2003;0(12):-
Objective To apply Gukang gold far-infrared magnetic therapeutic paste to the treatment of lateral epicondylitis.Methods 64 cases of lateral epicondylitis patients were randomly divided into treatment group and control group,each with 32 ones.The subjects from the treatment group were treated with Gukang gold far-infrared magnetic therapeutic paste,and the remained with ibuprofen sustained-release capsules.The results after one and two courses were analyzed statistically.Results After two-course treatment,the patient from the treatment group had an higher improvement rate than the others from the control group,with a P value less than 0.05.The treatment course of the treatment group was shorter than that of the control group,with a P value less than 0.05.Conclusion When compared with ibuprofen sustainedrelease capsule,Gukang gold far-infrared magnetic therapeutic paste is more effective for the treatment of lateral epicondylitis.
6.Studies on distribution and accumulative dynamic variation of bioactive components in Eucommia ulmoides
Xiangyang QI ; Weijun CHEN ; Shenghua ZHANG ;
Chinese Traditional and Herbal Drugs 1994;0(12):-
Object To study the effects of districts, seasonal variations and treatments in past harvest on the five main bioactive components in the barks and leaves of Eucommia ulmoides Oliv Methods The contents of them in the bark and leaves of E ulmoides were determined by RP HPLC Results The contents of (+) pinoresinol di O ? D glucopyranoside (PG), (+) syringaresinol di O ? D glucopyranoside (SG), chorgenic acid (CGA), geniposide (GP), geniposidic acid (GA) among the sample of E ulmoides from different growing districts were obvious difference Besides, the amount of different bioactive components in the same sample had no correlation Seasonal variation and different past harvest treatments had great influence on the bioactive component in E ulmoide. Based on the monthly variation of their main bioactive component, the suitable seasons for harvest of the barks and leaves of E ulmoides are April, May and July respectively, and intracellular enzymes in the fresh barks and leaves collected should be inactivated imediately before drying to avoid lossing the bioactive components In addition, between the barks and leaves of E ulmoides, the major bioactive component had great differences, but had complementarity Conclusion The districts, seasonal variatons and past harvest treatments have great effects on the contents of five main bioactive components in the barks and leaves of E ulmooides, and the barks couldn't be replaced by the leaves simply
7.Microscopical Study on the Stems of Chinese Crude Drugs Daji
Yanming JIN ; Hui CHEN ; Shenghua LI
Chinese Traditional and Herbal Drugs 1994;0(09):-
Histological characters of stems of Cirsium japonicum Fisch. ex DC. and C.chinense Gardn. et Champ. were described, compared and illustrated with line drawings. It was found that the following characters are important for disting uishing the two plants;(1) the type of stomata, vessels or fibres; (2) the presence or absence of secretory canal or tracheids.
8.Orbital fat flap for treating sunken upper eyelid in middle-aged and elder patients.
Shenghua LI ; Zhipeng CHEN ; Tao CHEN ; Zulie DING
Chinese Journal of Plastic Surgery 2014;30(6):414-417
OBJECTIVETo investigate the effect and its indication of orbital fat flap for treating sunken upper eyelid in middle-aged and elder patients.
METHODSThe upper middle orbital fat was transferred to the sunken area as a flat flap to correct Sunken upper eyelid at grade I, II, III. The depression depth was graded as I (<0.5 cm), as II (0.5-1.0 cm), as III ( >1.0 cm). From April 2011 to April 2012, 66 cases were treated and 49 cases were followed up for 12-15 months.
RESULTSAll patients with sunken upper eyelid were successfully treated using this procedure and no complications were encountered. Fat absorption was not observed. The effective rate was 90.9% (20/22) for grade I , 31.0% (18/58) for grade II and 0 for grade III (0/18), showing significant difference between any of two groups (P<0.05).
CONCLUSIONSThe orbital fat flap is effective for grade I Sunken upper eyelid with long- term effect.
Adipose Tissue ; transplantation ; Aged ; Blepharoplasty ; methods ; Eyelids ; surgery ; Female ; Humans ; Male ; Middle Aged ; Orbit ; Surgical Flaps ; transplantation
9.Early death causes in 2349 patients who receiving heart valve replacement
Haisheng CHEN ; Shenghua LIU ; Zhimin ZHONG ; Cuixian XIE ; Qiuwei LIN
Chinese Journal of Thoracic and Cardiovascular Surgery 2010;26(3):151-153
Objective The early causes of death were analyze in 2349 patients who had undergone heart valve replacement.Methods Methods From January 1995 to December 2007,2349 patients with heart valve diseases received heart valve replacement.1109 cases were male and 1240 were female.The mean age of the patients was(41±19)years old.1962 cases had rheumatic heart valve disease,308 had congenital heart valve disease,39 had infective endocarditis,29 underwent reintervention by heart valve replacement,11 had Marfan syndrome.34 cases with coronary heart disease underwent heart valve prosthesis implantation and coronary artery bypass grafting.Mitral valve replacement(MVR)was performed in 1333 patients,aortic valve replacement(AVR)in 271,double valves replacement(DVR)in 736 and tricuspid valve replacement(TVR)in 9.There were 3075 mechanical valves and 10 bioprosthetic valves.Results From 1995 to 1999,death occurred in 16 of the 235 cases,early mortality rate was 6.81%.From 2000 to 2004,death occurred in 35 of the 1087 cases,early mortality rate was 3.22%.From 2005 to 2007,there were 29 deaths among 1027 cases,with an early mortality rate of 2.82%.Overall early mortality rate was 3.40%.The early mortality rate was 2.32%(31 in 1333 cases)in patients who underwent MVR,3.32% (9 in 271)in patients who underwent AVR,5.24%(40 in 736)in patients who underwent DVR,5.50%(7 in 127)with LVEDD≥70 mm,4.60%(14 in 304)with LVEF<0.40,2.14%(9 in 419)with NYHA class II,2.42%(37 in 1529)with NYHA class Ⅲ,and 8.48%(34 in 401)with NYHA class IV.The causes of 80 deaths were low cardiac output syndrome in 31 cases(38.8%),renal failure in 14 cases(17.5%),arrhythmia in 10 cases(12.5%),pulmonary infections in 8 cases (10.0%).cerebrovascular accidentin 5(6.3%),left ventricular rupture in 5(6.3%),multisystem and organ failure in 5(6.3%),and other cause in 2 cases(2.5%).Conclusion The causes of early death after heart valve replacement are low cardiac output syndrome,renal failure,arrhythmia,pulmonary infection,cerebrovascular accident,left ventricular rupture and multisystem and organ failure.
10.Risk factors of liver metastasis in patients after radical resection of pancreatic cancer.
Meng ZEWU ; Chen YANLING ; Han SHENGHUA ; Zhu JINHAI ; Zhou LIANGYI
Chinese Journal of Oncology 2015;37(4):312-316
OBJECTIVETo analyze the risk factors of liver metastasis in patients after radical resection of pancreatic cancer.
METHODSOne hundred and twenty-four patients with non-metastatic, resectable pancreatic cancer treated in our department between 2006 and 2012 were included in this study. All of these patients underwent resection of the primary tumor combined with extensive lymph node dissection. The development of postoperative liver metastases was carefully followed up, and the clinicopathological factors and molecular characteristics were evaluated by univariate analysis and multivariate logistic regression using SPSS 16.0 software.
RESULTSForty-eight cases of liver metastases were found among the 124 cases of pancreatic cancer after radical surgery (38.7%). The rate of liver metastasis of pancreatic cancer after radical surgery in the age groups < 40, 40-60, and > 60 were 68.8%, 33.3% and 35.1%, respectively. The rate of liver metastasis in the body mass index (BMI) group < 20 kg/m2, 20-25 kg/m2, and > 25 kg/m2 were 21.6%, 44.1% and 52.6%, and the rate of liver metastasis in the time between the onset and diagnosis groups ≥ 3 months and < 3 months were 59.4% and 31.5%, respectively. The rate of liver metastasis in patients with preoperative fatty liver was 14.3% and it was 43.7% in patients without preoperative fatty liver. The rate of liver metastasis in patients of histological high, medium and low grade was 10.0%, 35.4% and 49.0%, respectively. The rate of liver metastasis in patients with venous tumor thrombus was 68.8% and it was 34.3% in patients without venous tumor embolus. The rate of liver metastasis in patients with postoperative chemotherapy was 31.2% and it was 51.1% in patients without postoperative chemotherapy. All those differences had statistical significance (P < 0.05). Univariate analysis revealed that age, body mass index (BMI), time between the onset and diagnosis, preoperative fatty liver, histological grading, tumor invasion depth, venous tumor embolus, and postoperative chemotherapy were significantly related to postoperative liver metastasis. Multivariate analysis revealed five statistically independent risk factors for postoperative liver metastasis: BMI, time between onset and diagnosis, preoperative fatty liver, histological grading, and venous tumor embolus.
CONCLUSIONSOur data suggest that patient's BMI, time between onset and diagnosis, histological grade, and venous tumor embolus are significantly correlated with postoperative liver metastases in patients with pancreatic cancer. Pancreatic cancer patients with preoperative fatty liver have less postoperative liver metastasis.
Adult ; Aged ; Body Mass Index ; Humans ; Liver Neoplasms ; secondary ; Lymph Node Excision ; Middle Aged ; Pancreatic Neoplasms ; pathology ; surgery ; Regression Analysis ; Risk Factors